Propionic Acid

Propionic Acid

SCHEMBL4153947

CCC(=O)O.O=c1[nH]c2ccc(S(=O)(=O)Cc3c(Cl)cccc3Cl)cc2c2cc[nH]c12

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.45
RXFP1 Q9HBX9 1/20 0.38
S1PR5 Q9H228 2/20 0.36
PTPN11 Q06124 2/20 0.34
DAO P14920 1/20 0.34
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.33
PARP1 P09874 2/20 0.33
AKR1B1 P15121 1/20 0.33
TP53 P04637 1/20 0.33
EGLN1 Q9GZT9 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
ALDH1A1 P00352 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4162521 0.87 FEN1 (0.44) RXFP1DAOKDM4EMAPTPARP1
Propionic Acid SCHEMBL4171787 0.82 BRAF (0.38) RXFP1DAOKDM4E
Propionic Acid SCHEMBL4155193 0.82 RXFP1 (0.41) RXFP1PTPN11KDM4EMAPTPARP1
Propionic Acid SCHEMBL4157930 0.82 RXFP1 (0.38) RXFP1PTPN11KDM4EPARP1ALDH1A1
Propionic Acid SCHEMBL4162918 0.81 BRAF (0.46) RXFP1KDM4EMAPT
Propionic Acid SCHEMBL4159383 0.81 ALDH1A1 (0.45) RXFP1KDM4EMAPTALDH1A1
Propionic Acid SCHEMBL4162945 0.79 KDM4E (0.47) RXFP1PTPN11KDM4EMAPTAKR1B1
Propionic Acid SCHEMBL4160658 0.79 TAS2R14 (0.49) RXFP1KDM4EPARP1GRIN2DGRIN3B
Propionic Acid SCHEMBL4162704 0.79 BRD4 (0.52) MAPTTP53ALDH1A1BRD4
Propionic Acid SCHEMBL4166927 0.79 RXFP1 (0.47) RXFP1KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 MET 1215/4885RXFP1 3999/4885S1PR5 2725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.